New Leaf Venture Associates III, L.P.
Insider CIK 1625656 · DCPH 10% owner · APTX 10% owner · HARP Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 85,750 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 686,000 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 299,430 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer | 2024-03-11 | 2024-03-11 | 1,463,386 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer | 2024-03-11 | 2024-03-11 | 395,783 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer | 2024-03-11 | 2024-03-11 | 10,000 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy deriv | 2023-10-25 | 2023-10-27 | 85,750 | — | $0 | 85,750 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy deriv | 2023-10-25 | 2023-10-27 | 686,000 | — | $0 | 686,000 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy | 2023-10-25 | 2023-10-27 | 171,500 | — | $0 | 395,783 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy | 2023-10-25 | 2023-10-27 | 1,372,000 | — | $0 | 1,463,386 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy | 2021-01-11 | 2021-08-12 | 235,294 | $17.00 | $4.00M | 913,860 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2019-08-16 | 2019-08-19 | 75,974 | $36.54 | $2.78M | 1,991,884 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2019-08-16 | 2019-08-19 | 28,626 | $37.01 | $1.06M | 1,963,258 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2019-08-16 | 2019-08-19 | 69,292 | $36.54 | $2.53M | 1,816,990 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2019-08-16 | 2019-08-19 | 26,108 | $37.01 | $966.3K | 1,790,882 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2019-08-15 | 2019-08-19 | 78,450 | $36.09 | $2.83M | 2,067,858 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2019-08-15 | 2019-08-19 | 71,550 | $36.09 | $2.58M | 1,886,282 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-14 | 464,281 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-14 | 1,564,272 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-14 | 464,281 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion | 2019-02-12 | 2019-02-14 | 1,564,272 | — | $0 | 1,564,272 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion | 2019-02-12 | 2019-02-14 | 464,281 | — | $0 | 2,028,553 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion | 2019-02-12 | 2019-02-14 | 464,281 | — | $0 | 464,281 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy | 2019-02-12 | 2019-02-14 | 214,286 | $14.00 | $3.00M | 2,242,839 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy | 2019-02-12 | 2019-02-14 | 214,285 | $14.00 | $3.00M | 678,566 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 33,022,786 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 28,895,188 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 15,233,315 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 6,712,986 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 1,047,450 | — | $0 | 1,047,450 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 1,197,076 | — | $0 | 2,244,526 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 552,208 | — | $0 | 2,796,734 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2018-06-25 | 2018-06-26 | 125,000 | $16.00 | $2.00M | 2,921,734 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2018-06-25 | 2018-06-26 | 125,000 | $16.00 | $2.00M | 368,345 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 243,345 | — | $0 | 243,345 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion deriv | 2017-10-02 | 2017-10-02 | 148,515 | — | $0 | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion deriv | 2017-10-02 | 2017-10-02 | 65,997 | — | $0 | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion deriv | 2017-10-02 | 2017-10-02 | 198,004 | — | $0 | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion deriv | 2017-10-02 | 2017-10-02 | 49,505 | — | $0 | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion deriv | 2017-10-02 | 2017-10-02 | 198,004 | — | $0 | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion | 2017-10-02 | 2017-10-02 | 372,883 | — | $0 | 1,771,308 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion | 2017-10-02 | 2017-10-02 | 1,118,722 | — | $0 | 1,398,425 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion | 2017-10-02 | 2017-10-02 | 279,703 | — | $0 | 279,703 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion | 2017-10-02 | 2017-10-02 | 1,118,722 | — | $0 | 1,957,832 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | P Buy | 2017-10-02 | 2017-10-02 | 375,000 | $17.00 | $6.38M | 2,146,308 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion | 2017-10-02 | 2017-10-02 | 839,110 | — | $0 | 839,110 | SEC↗ |